Professional Documents
Culture Documents
Ebookfiledocument - 934 (Download PDF) Bioactive Natural Products 1St Edition Atta Ur Rahman Editor Online Ebook All Chapter PDF
Ebookfiledocument - 934 (Download PDF) Bioactive Natural Products 1St Edition Atta Ur Rahman Editor Online Ebook All Chapter PDF
Atta-Ur-Rahman (Editor)
Visit to download the full and correct content document:
https://textbookfull.com/product/bioactive-natural-products-1st-edition-atta-ur-rahman-
editor/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-44-1st-edition-atta-ur-rahman/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-49-1st-edition-atta-ur-rahman-eds/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-50-1st-edition-atta-ur-rahman-eds/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-51-atta-ur-rahman-eds/
Studies in Natural Products Chemistry Volume 52 Atta-
Ur-Rahman (Eds.)
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-52-atta-ur-rahman-eds/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-53-atta-ur-rahman-eds/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-41-1st-edition-atta-ur-rahman-eds/
https://textbookfull.com/product/bioactive-natural-products-for-
pharmaceutical-applications-dilipkumar-pal/
https://textbookfull.com/product/studies-in-natural-products-
chemistry-volume-46-1st-edition-rahman/
Elsevier
Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, USA
No part of this publication may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopying, recording, or any information storage and
retrieval system, without permission in writing from the publisher. Details on how to seek
permission, further information about the Publisher’s permissions policies and our arrangements
with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency,
can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the
Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices, or
medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described herein. In
using such information or methods they should be mindful of their own safety and the safety of
others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors,
assume any liability for any injury and/or damage to persons or property as a matter of products
liability, negligence or otherwise, or from any use or operation of any methods, products,
instructions, or ideas contained in the material herein.
ISBN: 978-0-444-63602-7
ISSN: 1572-5995
Numbers in Parentheses indicate the pages on which the author’s contributions begin.
A.F. Barrero (1), Institute of Biotechnology, University of Granada, Avda.
Fuentenueva, Granada, Spain
R. Braz-Filho (231), Laboratório de Ci^encias Quı́micas, Centro de Ci^encias e
Tecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos
dos Goytacazes; ICE, Universidade Federal Rural do Rio de Janeiro, Seropedica,
Brazil
S.M. Cardoso (65), CERNAS, School of Agriculture, Polytechnic Institute of Coimbra
Bencanta, Coimbra; University of Aveiro, Aveiro, Portugal
M.D. Catarino (65), CERNAS, School of Agriculture, Polytechnic Institute of
Coimbra Bencanta, Coimbra, Portugal
G. Chen (209), School of Life Science and National Glycoengineering Research
Center, Shandong University, Jinan; Center for Gene and Cell Engineering,
Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced
Technology, Chinese Academy of Sciences, Shenzhen, PR China
K. Chen (209), School of Life Science and National Glycoengineering Research
Center, Shandong University, Jinan; Anhui Provincial Engineering Research Center
for Polysaccharide Drugs, Wannan Medical College, Wuhu, PR China
A.R. de Carvalho Jr. (231), Laboratório de Ci^encias Quı́micas, Centro de Ci^encias e
Tecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos
dos Goytacazes, Brazil
M.G. de Carvalho (231), ICE, Universidade Federal Rural do Rio de Janeiro,
Seropedica, Brazil
D. Dı́ez (137), Facultad de Ciencias Quı́micas, Universidad de Salamanca, Salamanca,
Spain
P.W. Dhore (287), Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India
V. Domingo (1), Institute of Biotechnology, University of Granada, Avda.
Fuentenueva, Granada, Spain
I. Duttagupta (29), Indian Association for the Cultivation of Science, Kolkata, West
Bengal, India
B. Fenert (399), Apteka “Dbam o Zdrowie”, Szczecinek, Poland
H. Gao (347), Institute of Traditional Chinese Medicine and Natural Products, College
of Pharmacy, Jinan University, Guangzhou, PR China
xi
xii Contributors
K.C. Ghosh (29), Indian Association for the Cultivation of Science, Kolkata,
West Bengal, India
A. Gil-Mesón (137), Facultad de Ciencias Quı́micas, Universidad de Salamanca,
Salamanca, Spain
J.N. Jacob (101), Organomed Corporation, Coventry, RI, United States
V. Karuppiah (417), Marine Biotechnology Laboratory, State Key Laboratory of
Microbial Metabolism and School of Life Sciences and Biotechnology, Shanghai
Jiao Tong University, Shanghai, PR China
D.M. Kokare (287), Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India
U.R. Lal (263), Birla Institute of Technology, Ranchi, Jharkhand, India
C. Li (209), Anhui Provincial Engineering Research Center for Polysaccharide Drugs,
Wannan Medical College, Wuhu, PR China
J. Li (347), State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants
Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry,
Chinese Academy of Sciences, Urumqi, PR China
Z. Li (417), Marine Biotechnology Laboratory, State Key Laboratory of Microbial
Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong
University, Shanghai, PR China
H. Makabe (323), Sciences of Functional Foods, Graduate School of Agriculture,
Shinshu University, Kami-ina, Nagano, Japan
I.S. Marcos (137), Facultad de Ciencias Quı́micas, Universidad de Salamanca,
Salamanca, Spain
R.F. Moro (137), Facultad de Ciencias Quı́micas, Universidad de Salamanca,
Salamanca, Spain
J.F. Quilez del Moral (1), Institute of Biotechnology, University of Granada, Avda.
Fuentenueva, Granada, Spain
A. Rabahi (65), Centre de Recherche Scientifique et Technique en Analyses Physico-
Chimiques CRAPC, Bou-Ismail, Tipaza, Algeria
N.A. Raut (287), Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India
S.D. Saoji (287), Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India
A.M.S. Silva (65), University of Aveiro, Aveiro, Portugal
A. Singh (263), Herbal Consultant, Phase-VII, Mohali, Punjab, India
S. Sinha (29), Indian Association for the Cultivation of Science, Kolkata, West Bengal,
India
W. Sun (417), Marine Biotechnology Laboratory, State Key Laboratory of Microbial
Metabolism and School of Life Sciences and Biotechnology, Shanghai Jiao Tong
University, Shanghai, PR China
O. Talhi (65), University of Aveiro, Aveiro, Portugal
I.J.C. Vieira (231), Laboratório de Ci^encias Quı́micas, Centro de Ci^encias e
Tecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Campos
dos Goytacazes, Brazil
Contributors xiii
xv
xvi Preface
Atta-ur-Rahman, FRS
International Center for Chemical and Biological Sciences
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi 75270
Pakistan
Chapter 1
Chapter Outline
Introduction 1 Miscellaneous 15
Radical C–H Functionalization 3 Azidation of
()-Leuconoxine 3 Tetrahydrogibberellic Acid 15
Ouabagenin 5 (+)-Myrrhanol C 17
Gracilioether F 7 Complanadines A and B 20
Metal-Catalyzed C–H (+)-Hongoquercin A 23
Functionalization 9 Concluding Remarks 25
Podophyllotoxin 9 References 26
Dictyodendrin A and
Dictyodendrin B 10
INTRODUCTION
C–H functionalization is the term used to describe the ability to cleave a C–H
bond in a molecule regio- and stereoselectively and thereby transform it into
new C–C, C–X (X ¼ nitrogen, oxygen, or halogen), or C–metal bonds.
These transformations can be also classified according to the chemical
species generated as radical, radical-cationic, radical-anionic, carbenic, cat-
ionic, or metal-catalyzed transformations (the term C–H activation is used
in the last case). A considerable number of reactions and their applications
in synthesis have already been described and reviewed covering different
types of processes [1–5]. The field of C–H functionalization appears to offer
the synthetic chemist the opportunity to find new disconnections almost at
*
Co-authors of this chapter.
Natural product
Pharmaceutical synthesis Material
targets science
C–C, C–X
diversification that has taken place in terms of the range of natural products
(their biosynthetic origin) and the C–H functionalization strategies executed
in their construction. Although highly desirable, it is impossible to cover all
the contributions that have appeared, and the authors apologize for any
omissions.
Witkop cyclization
H N BN
C
A
N N
D
O
O
(e) TFA, thiosalicylic acid, 88% CN NH
(f) DIBAL-H; (g) DMSO, SO3.Py Cl (l) BH3.SMe2, THF,
(h) Ph3P K CHCN, toluene, 80°C (i) Mg, MeOH, 85% then NaBO3, 51%
73% (3 steps) N N
H H
(j) LiAlH4, Et2O
O
1d (k) Cl 1e
OH DIC, DMAP
73% (2 steps)
O
NH Cl O O
Cl
(m) hu (254 nm), Na2CO3, Witkop Transannular
HN HN
MeOH, rt cyclization cyclization
N N
H 49% N –
H –Cl H
5:2.5:1:1
HO HO HO
1f
O
NH
O HN OH
O HN
N
H
Transannular H 1h
HN 1g
cyclization HO
+
N O O
H H H
HO N N
Transient iminium ion N N
H H
HO
1i OH
1j
O O O
H H H
N (n) TPAP, NMO, MeCN N N
N N N
H 50%
HO HO O
1j (–)-Leuconoxine (1)
(2,7) 1h together with the desired cyclized product at position C-3 in the
heterocycle 1j.
The key C–H functionalization step features a photoinduced electron trans-
fer from the excited state of the indolic system to the chloroacetamide moiety.
Thus, the diradical cation cyclises forming a transient iminium ion that
is trapped intramolecularly affording compounds 1i and 1j (Scheme 1.2).
Recent Accomplishments in the Total Synthesis Chapter 1 5
It should be noted that the global yield for this transformation was modest;
however, in this case, the power of the C–H functionalization lies in the rapid
assembly of the terpene-indolic system in one chemical operation in a cascade
fashion.
At the end of the synthesis to obtain ()-leuconoxine (1), 1j was oxidized
with catalytic TPAP (tetrapropylammonium perruthenate) which establishes
the final fenestrane skeleton of ()-leuconoxine in 50% yield (Scheme 1.2).
Ouabagenin
Ouabagenin (2) is the aglycon of ouabain. The glycoside steroid was isolated
in 1888 from the bark of the African ouabio tree (Acokanthera ouabio), and
the aglycon was subsequently isolated in 1942 by Mannich and Siewert
[32–34]. Ouabagenin (2) is encompassed in the family of the cardenolides
(from Greek kardia ¼ heart), a subtype of the family of steroids. Steroids are
described as modified (nor) polycyclic triterpenoids lacking from three methyl
groups (two in position C-4 in the A ring and one at the junction of the B–C
rings), and they are biosynthetically formed from the mevalonic acid pathway
(Fig. 1.3).
From the medicinal point of view, ouabagenin (2) displays cardiotonic
activity through inhibition of the Na+/K+-ATPase, an enzyme found in the
plasma membrane of all eukaryotic cells. For this reason, it has proved to
be of great value in developing potent inotropic agents for the treatment of
congestive heart failure. Topologically speaking, cardenolides possess a
6-6-6-5 carbocyclic skeleton where both A/B and C/D ring fusions are cis
in contrast to the typical steroid structure. In the D ring, a characteristic bute-
nolide framework is found at C-17, and this motif is in part responsible for the
high bioactivity of this molecules.
However, despite its promising bioactive profile, the first total synthesis
of this molecule was not achieved until 2008 due to its complexity [35].
The impressive synthetic composition carried out by Deslongchamps et al.
employed a polyanionic cyclization as key step that afforded a few milligrams
of product at the end of the sequence.
O
C–H oxidations
O O
19
O 11
HO 1 C H
H B D
HO HO 14
OH 5
HO A
HO
Ouabagenin (2) Steroid skeleton (cardenolide)
O O
O O O
HO O O
H (a) H+, ethylenglycol H I
(c) NIS, Li2CO3 H
81% 85%
H H O H H
O H H
O
(b) hυ 3–5 days O O
Adrenosterone (2a) solid-state (68%) 2b 2c
solution (43%)
O O O
O O (g) H2O2 O O
(d) TiCl4; AgOAc HO O (e) H2O2
HO
O HO
19 H 50% (3 steps) O H
71% (f) SeO2 H
H H H H H H
O O O
2d O 2e O 2f
O O
O O O
HO O O (k) Li, NH3
O HO
HO H H (l) PPTS, O
(i) PPTS, Me2CO O H
(h) Al-Hg, H2O 56% Me2CO O
H H (j) LiBEt3H
5 H H H H
O
HO 63% (2 steps) O 69% (2 steps)
O O O
B B
2g Et 2h 2i O
Et
O
O O
HO HO (p) N2H4; I2; Et3N
(m) TMSOTf, PdII O O 17 (q) CuTC, HO
O H O H O
(n) SiO2, DIPEA (o) O2, Co(acac)2 Pd(PPh3)4, A O H
14
H H OH
F H OH
86% 42% (2 steps)
F3C F O O O O
B B O O
B
Et 2j Et 2k 2l
F F Et
F (Protected ouabageninone)
55% (2 steps)
O
O
O
O
O A
(r) [Co2B]
O
(s) Me2N NtBu HO
HO HO Bu3Sn
NMe2 O HO H
O H
(t) HCl H OH
70% (2 steps) H OH
90% HO HO
O O
B
Ouabagenin (2)
Et 2m
Adrenosterone (2a) obtained from cortisone acetate was the starting point of
the synthetic sequence (Scheme 1.3). Ketalization of the less-hindered ketones
(rings A and D) and abstraction of the g hydrogen in a Norrish type II photo-
chemical transformation functionalized the C-19 position obtaining 2b in
68%. The radical transformation was carried out in solid state yielding better
yields than in solution. The strained cyclobutanol ring was then selectively frag-
mented after exposure of 2b to oxidative reaction conditions using
N-iodosuccinimide (NIS), and 2c was generated in 85% yield. Deprotection
of the A-ring ketal and hydrolysis of the C-19 iodide was achieved in a two-step
protocol TiCl4/AgOAc to afford 2d in 71% creating the new hydroxyl function.
The stereochemistry of the primary hydroxyl achieved in this intermediate 2d
would serve afterward to direct the hydroxyl functions with facial selectivity
at C-1 and C-5 in 2g. As result of epoxidation of enones 2d and later 2e, the
diepoxide 2f was obtained (50% three steps). Exposure of 2f to the amalgam
Al-Hg promoted the epoxide opening, and 2g was obtained in 56% yield.
After several transformations, enone 2j was obtained using Saegusa’s pro-
tocol; remarkably, after extensive survey of conditions, employment of per-
fluorotoluene gave a productive transformation from 2i to 2j in 55% yield,
while suppressing epimerization at C-14.
The last hydroxyl at C-14 (C–D rings junction) was inserted using
Mukaiyama hydration onto enone 2j in 86% yield, and the protected key
intermediate 2k was used to construct a library of ouabagenin analogs by
exchanging the characteristic butenolide framework of the natural product
for other subunits. The last steps comprised the transformation of the ketone
at C-17 into the vinyl iodide and Stille cross-coupling (Fürstner modification)
after which the cross-coupling product 2l was obtained in 42%. Reduction of
the dienoate 2l and isomerization of the resulting olefin (albeit dr ¼ 3:1 was
observed in this step) provide 2m (70% yield two steps). Finally, global
deprotection of 2m procured stereoselectively ouabagenin (2).
Despite the fact that the classical chemistry of steroids has been exten-
sively exploited, this example shows us that the beautiful frameworks of these
compounds designed by nature allow different types of C–H functionalization
reactions. These reactions in final term are crucial in supplying scalable
amounts of material no previously achieved by conventional methods in some
fully elaborated members of the family of steroids.
Gracilioether F
Gracilioether F (3) is an oxygenated polyketide natural product isolated from
the apolar extracts of the marine sponge Plakinastrella mamillaris. The
marine invertebrate was first collected in the Fiji Islands, and this organism
has been a rich source of polyketides showing antimicrobial, antitumor, anti-
fungal, and antiparasitic properties [38,39]. Gracilioether F (3) possesses an
unusual tricylcic core and five contiguous stererocenters which distinguish it
8 Studies in Natural Products Chemistry
from other gracilioethers with fewer rings that have been found in the sponge
Agelas gracilis. Thus a plausible biosynthetic origin of the gracilioether fam-
ily from a common furanylidene motif was postulated by Perkins et al.
[40,41] (Fig. 1.4).
In Brown’s synthetic endeavor, two key steps were employed: (a) a new
[2 +2] cycloaddition between an alkene and monosubstituted ketene catalyzed
by Lewis acid and (b) a late-stage oxidation (C–H functionalization step) to
build the lactone ring [42].
The advanced intermediate cyclobutanone 3c was assembled through a
ketene–alkene [2 + 2] cycloaddition. The methodology developed by the same
authors generated the alkenyl ketene in situ from an unsaturated acid chloride
3a to give 3c in 65% yield and good diastereomeric ratio (20:1) after conden-
sation (Scheme 1.4). Then alkylation was carried out to obtain 3d in high
C–H oxidation
Et O Et H R
H
O R1 R O
O
Et H Et Et H Et
O O
O R
Gracilioether F (3) Gracilioether skeleta
AlMe3
O Et
O (a) AlMe3 (2.5 equiv) H O
i-Pr2NEt (1.1 equiv) Me C 3b
Ph
Cl
Ph H
Me [2 + 2] H
3a CH2Cl2, –78 to –45°C Et
Cycloaddition Me
+ Generation of Ph
Et 65% yield, 20:1 d.r. 3c
ketenes in situ
2 equiv
3b Et
(d) O3, CH2Cl2, –78°C then
Et H (e) NaClO2, NaH2PO4, t-BuOH,
O Et H O Et H O
(c) H2O2, NaOH isobutylene
(b) KHMDS Et MeOH, 22°C 22°C
O O
THF, –78 °C, H 61% yield Et 83% yield Et
Et H H
EtI, –78 to 22°C Me Et Me Et
Ph HO O
91% yield, 20:1 d.r. 3d 3e
Ph 3f
Gram scale
Et H Et H O
O (f) Cu(OAc)2 (1 equiv), H2O2,
H MeCN, 0°C
4 O
Et O
Et Et Et
10%, 88% brsm H
H O
HO O O
3f Gracilioether F (3)
OH
H R
O 4 H
O O
O Ar1 O
H O O
H O
C–H arylation
Ar2
MeO OMe
OMe
Podophyllum lignans
Podophyllotoxin (4)
O O
O Br DCM/ NaOH O
MeO2C
BnNEt Cl SMe HN
3 H
4a 2 steps N
(b) n-BuLi, MgBr2
1 recrystallization
MeS
4b O
4c
(+)-Hongoquercin A
Professors Baran and Yu envisioned the synthesis of (+)-hongoquercin (9)
by taking advantage of the invention of a number of C–H functionalizations
of benzoic acids derivatives developed in the laboratories of Professor Yu
[73–77]. Apart from hongoquercin, the authors showed how C–H functionali-
zations proved to be a valid strategy to “the divergent functionalization of nat-
ural product cores” [78]. Thus, a number of hongoquercin derivatives were
prepared using this approach (Fig. 1.10).
(+)-Hongoquercin A (9) was isolated from the extracts of an unidentified
fungus in 1998. This substance exhibits activity against methicillin-resistant
Staphylococcus aureus and vancomycin-resistant Enterococcus faecium [79].
The synthetic route toward hongoquercin commenced with (+)-chromazonarol
(9a), a compound available from commercial (+)-sclareolide [80]. Hydroxycar-
bonylation of the corresponding triflate of 9a afforded the required benzoic
acid derivative 9b. Pd-mediated C–H methylation required extensive research
to optimize of reaction conditions, a study carried out with m-toluic acid
as model. It was found that the presence of both Boc-Phe-OH as ligand and
1,4-benzoquinone was essential for the success of the transformation. Under
the optimized conditions shown in Scheme 1.16, monoalkylated derivative 9c
was produced in 60% yield. At this point, only a C–H hydroxylation was needed
to reach the target (+)-hongoquercin (9). However, when 9c was subjected to
the previously reported protocol for the Pd(II)-catalyzed hydroxylation of
arenes [77], no (+)-hongoquercin (9) was detected, and only a 10–15% yield
of this compound was detected when the pressure of O2 was raised to 10 atm.
The authors then considered previous studies by Professor Yu showing that
electron-deficient aryl amides can enable C–H activation where other directing
groups failed [81]. In the event, once the corresponding amide 9d formed, C–H
methylation took place in reasonable yield. At this point, and after extensive
C–H oxidation
CO2H OH
HO Me
O C–H methylation O
H H